Trial Profile
The Effect of Everolimus on the Pharmacokinetics of Tacrolimus in Renal Transplant Patients, and the Effect of ABCB1CYP3A4CYP3A5PORGenetic Polymorphism on the Two Drugs
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Mycophenolate mofetil; Tacrolimus
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- 22 Jul 2019 Status changed from recruiting to completed.
- 10 Jul 2018 Planned End Date changed from 1 Jan 2018 to 1 Feb 2019.
- 10 Jul 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Feb 2019.